LIVE STREAMING on Fondazione Menarini's Website or APP
Immersive Experience in the 3D World
We are pleased to invite you for a unique, easy and engaging new communication experience:
the “Round Table on NEW BIOLOGICAL INSIGHTS AND NOVEL DRUGS IN ACUTE LEUKEMIA” in 3D!
Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are clonal disorders resulting from acquired somatic mutations in hematopoietic progenitor cells that lead to the dysregulation of differentiation and proliferation of hematopoietic cells.
AML and ALL are heterogeneous diseases with respect to presentation and clinical outcome.
An increasing understanding of molecular aberrations that trigger the development of acute leukemia, and growing use of next generation sequencing, are advancing the development of investigational drugs targeting driver genetic mutations.
This round table debate will focus on novel diagnostic and therapeutic tools for the management of AML and ALL. The role of minimal residual disease detection for a sharper management of acute leukemia will be highlighted.
Section of Hematology &
Romagna Metropolitan Transplant Network
Hospital of Ravenna
Istituto Scientifico Romagnolo per lo Studio
e la Cura dei Tumori (I.R.S.T.)
Meldola - FC, IT